{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:12:18Z","timestamp":1791335538260,"version":"4.3.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,12,4]]},"DOI":"10.1093\/jnci\/94.23.1773","type":"journal-article","created":{"date-parts":[[2002,12,3]],"date-time":"2002-12-03T21:23:16Z","timestamp":1038950596000},"page":"1773-1779","source":"Crossref","is-referenced-by-count":294,"title":["Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers"],"prefix":"10.1093","volume":"94","author":[{"given":"S. A.","family":"Narod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["CancerSpectrum Knowledge Environment"],"original-title":[],"link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/94\/23\/1773\/9849275\/1773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T11:16:11Z","timestamp":1503573371000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/94.23.1773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,4]]},"references-count":0,"journal-issue":{"issue":"23"},"URL":"https:\/\/doi.org\/10.1093\/jnci\/94.23.1773","relation":{},"ISSN":["1460-2105"],"issn-type":[{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,4]]}}}